DZ2181A1 - Dénvés d'oxadiazole et de thiadiazole antagonistesdes récepteurs muscariniques. - Google Patents

Dénvés d'oxadiazole et de thiadiazole antagonistesdes récepteurs muscariniques.

Info

Publication number: DZ2181A1
Authority: DZ; Algeria
Prior art keywords: oxadiazole; receptor antagonist; muscarinic receptor; thiadiazole derivatives; thiadiazole
Prior art date: 1996-02-22

Application number

DZ970027A

Other languages

English (en)

Inventor

Alexander Roderick Mackenzie

Anthony Wood

Robert John Bass

Original Assignee

Pfizer Res & Dev Company

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-02-22

Filing date

1997-02-19

Publication date

2002-12-01

1997-02-19 Application filed by Pfizer Res & Dev Company filed Critical Pfizer Res & Dev Company

2002-12-01 Application granted granted Critical

2002-12-01 Publication of DZ2181A1 publication Critical patent/DZ2181A1/fr

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Urology & Nephrology (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Hydrogenated Pyridines (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

DZ970027A 1996-02-22 1997-02-19 Dénvés d'oxadiazole et de thiadiazole antagonistesdes récepteurs muscariniques. DZ2181A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB9603755.1A GB9603755D0 (en)	1996-02-22	1996-02-22	Therapeutic agents

Publications (1)

Publication Number	Publication Date
DZ2181A1 true DZ2181A1 (fr)	2002-12-01

Family

ID=10789217

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DZ970027A DZ2181A1 (fr)	1996-02-22	1997-02-19	Dénvés d'oxadiazole et de thiadiazole antagonistesdes récepteurs muscariniques.

Country Status (42)

Country	Link
US (1)	US5977142A (fr)
EP (1)	EP0885218B1 (fr)
JP (1)	JP3148252B2 (fr)
KR (1)	KR100315934B1 (fr)
CN (1)	CN1089340C (fr)
AP (1)	AP751A (fr)
AR (1)	AR005916A1 (fr)
AT (1)	ATE200899T1 (fr)
AU (1)	AU712230B2 (fr)
BG (2)	BG102699A (fr)
BR (1)	BR9707733A (fr)
CA (1)	CA2247164C (fr)
CO (1)	CO4650040A1 (fr)
CZ (1)	CZ292650B6 (fr)
DE (1)	DE69704701T2 (fr)
DK (1)	DK0885218T3 (fr)
DZ (1)	DZ2181A1 (fr)
ES (1)	ES2156357T3 (fr)
GB (1)	GB9603755D0 (fr)
GR (1)	GR3036032T3 (fr)
HN (1)	HN1997000020A (fr)
HR (1)	HRP970098B1 (fr)
HU (1)	HUP9900501A3 (fr)
ID (1)	ID16642A (fr)
IL (1)	IL125413A (fr)
IS (1)	IS4803A (fr)
MY (1)	MY129729A (fr)
NO (1)	NO313414B1 (fr)
NZ (1)	NZ331039A (fr)
OA (1)	OA10838A (fr)
PE (1)	PE42798A1 (fr)
PL (1)	PL186879B1 (fr)
PT (1)	PT885218E (fr)
RU (1)	RU2162848C2 (fr)
SK (1)	SK283461B6 (fr)
TN (1)	TNSN97039A1 (fr)
TR (1)	TR199801644T2 (fr)
TW (1)	TW492961B (fr)
UA (1)	UA61068C2 (fr)
WO (1)	WO1997030994A1 (fr)
YU (1)	YU35698A (fr)
ZA (1)	ZA971513B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6107313A (en) *	1998-10-02	2000-08-22	Combichem, Inc.	Dopamine receptor antagonists
ATE375340T1 (de) *	2001-02-21	2007-10-15	Nps Pharma Inc	Heteropolycyclische verbindungen und deren verwendung als metabotrope glutamatrezeptorantagonisten
GB0510141D0 (en) *	2005-05-18	2005-06-22	Addex Pharmaceuticals Sa	Novel compounds B3
GB0510139D0 (en) *	2005-05-18	2005-06-22	Addex Pharmaceuticals Sa	Novel compounds B1
GB0516313D0 (en) *	2005-08-08	2005-09-14	Argenta Discovery Ltd	Azole derivatives and their uses
WO2008017827A2 (fr) *	2006-08-08	2008-02-14	Argenta Discovery Limited	Composés chimiques
JP2010501533A (ja) *	2006-08-21	2010-01-21	アージェンタディスカバリーリミテッド	Ｍ３レセプター調節物質として有用な窒素含有複素環化合物
WO2008096093A1 (fr) *	2007-02-06	2008-08-14	Argenta Discovery Ltd.	Dérivés d'oxazole et de thiazole et leurs utilisations
GB0702382D0 (en) *	2007-02-07	2007-03-21	Argenta Discovery Ltd	New salt
GB0702416D0 (en) *	2007-02-07	2007-03-21	Argenta Discovery Ltd	New combination
GB0702385D0 (en) *	2007-02-07	2007-03-21	Argenta Discovery Ltd	New combination
GB0702414D0 (en) *	2007-02-07	2007-03-21	Argenta Discovery Ltd	Oxazole and thiazole derivatives and their uses 2
US7846955B2 (en) *	2007-02-07	2010-12-07	Astrazeneca Ab	Salt
CN101657452A (zh) *	2007-02-15	2010-02-24	阿金塔探索有限公司	作为m3毒蕈碱性受体的杂环衍生物
WO2009098453A1 (fr) *	2008-02-06	2009-08-13	Astrazeneca Ab	Azonia bicycloalcanes comme antagonistes du récepteur d'acétylcholine muscarinique m3
US8263623B2 (en)	2008-07-11	2012-09-11	Pfizer Inc.	Triazol derivatives useful for the treatment of diseases
WO2010018352A1 (fr) *	2008-08-12	2010-02-18	Argenta Discovery Limited	Composés hétérocycliques utilisés dans le traitement de maladies impliquant l’activation améliorée du récepteur m3
JP2014065387A (ja) *	2012-09-25	2014-04-17	Showa Corp	自動二輪車の車高調整装置

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ219646A (en) *	1986-03-27	1990-10-26	Merck Sharp & Dohme	Oxadiazole derivatives of azacyclics for treating cns disorders
IL88846A0 (en) *	1988-01-08	1989-07-31	Merck Sharp & Dohme	Lipophilic oxadiazoles,their preparation and pharmaceutical compositions containing them
US5043345A (en) *	1989-02-22	1991-08-27	Novo Nordisk A/S	Piperidine compounds and their preparation and use
CA2126976A1 (fr) *	1991-12-31	1993-07-08	Hisashi Takasugi	Derives d'oxadiazole inhibiteurs de l'activite de l'acetylcholinesterase et agonistes muscariniques
TW360653B (en) *	1995-03-01	1999-06-11	Janssen Pharmaceutica Nv	A oxadiazole compound having colon motility stimulating properties, its preparation process and its pharmaceutical composition

1996
- 1996-02-22 GB GBGB9603755.1A patent/GB9603755D0/en active Pending
1997
- 1997-01-21 TW TW086100642A patent/TW492961B/zh not_active IP Right Cessation
- 1997-02-03 HN HN1997000020A patent/HN1997000020A/es unknown
- 1997-02-04 AT AT97902337T patent/ATE200899T1/de not_active IP Right Cessation
- 1997-02-04 PL PL97328633A patent/PL186879B1/pl not_active IP Right Cessation
- 1997-02-04 DE DE69704701T patent/DE69704701T2/de not_active Expired - Fee Related
- 1997-02-04 SK SK1123-98A patent/SK283461B6/sk unknown
- 1997-02-04 CN CN97192486A patent/CN1089340C/zh not_active Expired - Fee Related
- 1997-02-04 WO PCT/EP1997/000525 patent/WO1997030994A1/fr not_active Ceased
- 1997-02-04 IL IL12541397A patent/IL125413A/en not_active IP Right Cessation
- 1997-02-04 PT PT97902337T patent/PT885218E/pt unknown
- 1997-02-04 EP EP97902337A patent/EP0885218B1/fr not_active Expired - Lifetime
- 1997-02-04 RU RU98117457/04A patent/RU2162848C2/ru not_active IP Right Cessation
- 1997-02-04 JP JP52974197A patent/JP3148252B2/ja not_active Expired - Fee Related
- 1997-02-04 HU HU9900501A patent/HUP9900501A3/hu unknown
- 1997-02-04 NZ NZ331039A patent/NZ331039A/en unknown
- 1997-02-04 US US09/117,556 patent/US5977142A/en not_active Expired - Fee Related
- 1997-02-04 KR KR1019980706534A patent/KR100315934B1/ko not_active Expired - Fee Related
- 1997-02-04 CA CA002247164A patent/CA2247164C/fr not_active Expired - Fee Related
- 1997-02-04 BR BR9707733A patent/BR9707733A/pt not_active Application Discontinuation
- 1997-02-04 CZ CZ19982678A patent/CZ292650B6/cs not_active IP Right Cessation
- 1997-02-04 TR TR1998/01644T patent/TR199801644T2/xx unknown
- 1997-02-04 AU AU16014/97A patent/AU712230B2/en not_active Ceased
- 1997-02-04 ES ES97902337T patent/ES2156357T3/es not_active Expired - Lifetime
- 1997-02-04 DK DK97902337T patent/DK0885218T3/da active
- 1997-02-13 CO CO97007550A patent/CO4650040A1/es unknown
- 1997-02-14 PE PE1997000104A patent/PE42798A1/es not_active Application Discontinuation
- 1997-02-19 TN TNTNSN97039A patent/TNSN97039A1/fr unknown
- 1997-02-19 DZ DZ970027A patent/DZ2181A1/fr active
- 1997-02-20 HR HR970098A patent/HRP970098B1/xx not_active IP Right Cessation
- 1997-02-20 AR ARP970100667A patent/AR005916A1/es unknown
- 1997-02-20 AP APAP/P/1997/000930A patent/AP751A/en active
- 1997-02-21 ZA ZA971513A patent/ZA971513B/xx unknown
- 1997-02-21 MY MYPI97000654A patent/MY129729A/en unknown
- 1997-02-21 ID IDP970521A patent/ID16642A/id unknown
- 1997-04-02 UA UA98094939A patent/UA61068C2/uk unknown
1998
- 1998-07-21 IS IS4803A patent/IS4803A/is unknown
- 1998-08-14 OA OA9800143A patent/OA10838A/en unknown
- 1998-08-19 BG BG102699A patent/BG102699A/xx unknown
- 1998-08-19 BG BG102699A patent/BG63971B1/bg unknown
- 1998-08-21 NO NO19983871A patent/NO313414B1/no not_active IP Right Cessation
- 1998-08-21 YU YU35698A patent/YU35698A/sh unknown
2001
- 2001-06-13 GR GR20010400885T patent/GR3036032T3/el not_active IP Right Cessation

Also Published As

Publication number	Publication date
GB9603755D0 (en)	1996-04-24
RU2162848C2 (ru)	2001-02-10
AU1601497A (en)	1997-09-10
BG102699A (en)	1999-09-30
CN1089340C (zh)	2002-08-21
SK283461B6 (sk)	2003-08-05
ZA971513B (en)	1998-08-21
PL328633A1 (en)	1999-02-15
SK112398A3 (en)	2000-04-10
TR199801644T2 (xx)	1998-11-23
PL186879B1 (pl)	2004-03-31
ID16642A (id)	1997-10-23
HRP970098B1 (en)	2001-12-31
MY129729A (en)	2007-04-30
OA10838A (en)	2001-08-13
TW492961B (en)	2002-07-01
IS4803A (is)	1998-07-21
KR19990087143A (ko)	1999-12-15
NZ331039A (en)	1999-10-28
DE69704701D1 (de)	2001-06-07
UA61068C2 (en)	2003-11-17
AP751A (en)	1999-07-12
AU712230B2 (en)	1999-11-04
NO313414B1 (no)	2002-09-30
CA2247164C (fr)	2004-11-16
HN1997000020A (es)	1997-06-05
IL125413A (en)	2002-09-12
PT885218E (pt)	2001-08-30
JP3148252B2 (ja)	2001-03-19
YU35698A (sh)	1999-07-28
ATE200899T1 (de)	2001-05-15
DE69704701T2 (de)	2001-08-16
HRP970098A2 (en)	1999-04-30
ES2156357T3 (es)	2001-06-16
JPH11504051A (ja)	1999-04-06
KR100315934B1 (ko)	2002-03-21
CO4650040A1 (es)	1998-09-03
PE42798A1 (es)	1998-08-18
AP9700930A0 (en)	1997-04-30
GR3036032T3 (en)	2001-09-28
BR9707733A (pt)	1999-07-27
US5977142A (en)	1999-11-02
CZ267898A3 (cs)	1999-08-11
CZ292650B6 (cs)	2003-11-12
NO983871L (no)	1998-08-21
HK1018274A1 (en)	1999-12-17
HUP9900501A2 (hu)	1999-06-28
DK0885218T3 (da)	2001-05-28
AR005916A1 (es)	1999-07-21
NO983871D0 (no)	1998-08-21
BG63971B1 (bg)	2003-08-29
CN1211981A (zh)	1999-03-24
WO1997030994A1 (fr)	1997-08-28
IL125413A0 (en)	1999-03-12
CA2247164A1 (fr)	1997-08-28
TNSN97039A1 (fr)	2005-03-15
EP0885218A1 (fr)	1998-12-23
EP0885218B1 (fr)	2001-05-02
HUP9900501A3 (en)	2001-02-28

Publication	Publication Date	Title
DZ2181A1 (fr)	2002-12-01	Dénvés d'oxadiazole et de thiadiazole antagonistesdes récepteurs muscariniques.
EP0934305A4 (fr)	2001-04-11	Antagonistes de l'integrine
EP0946164A4 (fr)	2000-08-23	Antagonistes de l'integrine
DE69719354D1 (de)	2003-04-03	Muscarin-antagonisten
EP0865867A4 (fr)	2002-05-15	Dispositif d'usinage
EP1007026A4 (fr)	2002-08-07	Antagonistes d'integrine
FR2765931B1 (fr)	2000-11-24	Dispositif d'amortissement
NO972016D0 (no)	1997-04-30	Indolyl-Y-reseptorantagonister
DE69734833D1 (de)	2006-01-12	Vitronektin rezeptor antagonisten
EP1100506A4 (fr)	2002-06-26	Antagonistes des recepteurs de l'integrine
DE69728392D1 (de)	2004-05-06	Indolderivate verwendbar als endothelinrezeptorantagonisten
EP0612244A4 (fr)	1995-05-17	Antagonistes recepteurs de l'endotheline.
BRPI9810519B1 (pt)	2012-02-22	derivados de 4''-substituìdo-9-desoxo-9a-aza-9a-homoeritromicina a e composição farmacêutica compreendendo os mesmos.
BR9407933A (pt)	1996-11-26	Antagonistas de receptores de endotelina
DZ1773A1 (fr)	2002-02-17	Antagonistes de récepteurs d'endothéline.
EP0810994A4 (fr)	1998-05-06	Antagonistes des recepteurs de fibrinogene
NO975976L (no)	1998-06-22	Vitronektinreseptor-antagonister, fremstilling samt anvendelse derav
EP0885205A4 (fr)	2002-11-27	Antagonistes des recepteurs de fibrinogenes
NO975975D0 (no)	1997-12-19	Vitronektinreseptor-antagonister, fremstilling samt anvendelse derav
TR199800988A3 (tr)	1998-12-21	5' Deoksi-Sitidin türevleri.
FR2748318B1 (fr)	2001-03-30	Dispositif d'injection de plasma
DE69427921D1 (de)	2001-09-13	Epsilon opioid rezeptor und dessen verwendungen
FI894675A7 (fi)	1990-04-05	Muskarinreceptorantagonister.
DE69616364D1 (de)	2001-11-29	Endothelinrezeptorantagonisten
EP0999205A4 (fr)	2000-05-31	Composes d'aminocycloalcane